纵向蛋白学揭示了PI3K-PAK1轴作为复发性结直肠肝转移的潜在目标

Daigo Gunji1, Yuichi Abe2, Satoshi Muraoka3

  • 1Laboratory of Proteomics for Drug Discovery, Center for Drug Design Research, National Institute of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan; Department of Surgery, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.

Cell reports
|December 17, 2024
PubMed
概括

对5-FU化疗耐药的结肠直肠癌肝脏转移显示已激活的PAK激酶. PI3K抑制剂,如可潘利西布,显示出治疗这些耐药瘤的前景.